Palliative CareDESANCT02845817

Requests for Euthanasia and Assisted Suicide

A study testing Qualitative research in people with Palliative Care and End of Life, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

This study take place in the palliative care units of Burgundy-Franche-Comté regions and at the Maison Médicale Jeanne Garnier. The main aim of this project is to analyze and understand the meaning of explicit requests to hasten death (euthanasia and assisted suicide). Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Palliative Care, End of Life, Euthanasia
What is being tested?: Qualitative research
Could I receive a placebo?: No, everyone receives an active treatment
How many people: 31 participants
Where: 1 siteFrance
Study dates: Sep 2014to Jun 2015
Phase: Interventional
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Who may be able to join

Adult not under guardianship or curatorship,
Hospitalized in palliative care units of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier in Paris,
At the end of life due to advanced stage disease or a major change in the state of health of an elderly person,
They have made an explicit request for euthanasia or assisted suicide,
They are in capacity to meet researchers for interview,
Having consented to interviews,
They are covered by the French social security system.

Who cannot join

Adult under guardianship or curatorship,
They are underage,
They are not hospitalized in Palliative Care Unit of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier,
The request was expressed by another person or not explicit,
They didn't consent to interviews,
The request appears in the context of a situation other than illness or a general change in state of health
They are not in capacity to meet researchers for interviews.

Trial locations and contacts

1 site in 1 country.

France1 site

CHRU Besançon - Palliative Care Unit
Besançon, Bourgogne-Franche-Comté, 25000

Other trials in France

About this study

Official title: Requests for Euthanasia and Assisted Suicide: a Prospective, Multicenter and Qualitative Study of Their Frequency and Characteristics, of Patients' Motivations and Their Evolution

This involves conducting interviews with patients, carers to whom the request has been expressed and a relative chosen by the patient. This study aims to describe the request over time. This will be done through two series of interviews, one as soon as it is first expressed, then one week later.

Conditions: Palliative Care, End of Life, Euthanasia, Assisted Suicide, Qualitative Research
Being tested: Qualitative research
Medical subject headings: Death, Suicide, Assisted

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Qualitative researchOther
Semi-structured interviews

Study groups in NCT02845817
Study group	Role	What they receive
Qualitative research	Other	Semi-structured interviews Receives: Other: Qualitative research

What is being measured

The primary outcome is the main question the study is designed to answer.

70 semi-structured interviews
Qualitative data analysis - Theoretical concept saturation and thematic analyses. [analyze and understand the meaning of explicit requests to hasten death (euthanasia and assisted suicide)]
Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Sep 2014Jun 2015

First posted27 Jul 2016 (estimated)
Study startSep 2014
Primary completionJun 2015
Study completionJun 2015

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Palliative CareStudies of the same condition, open and under way.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Interventional
Phase: Phase N/A
Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Enrolment: 31 participants (actual)

IDs, dates and publications

ClinicalTrials.gov ID: NCT02845817
Sponsor's protocol ID: DESA
Acronym: DESA
Status last verified: Jul 2016
First submitted: 18 Jul 2016
Last updated: 27 Jul 2016
Results posted: No
Data monitoring committee: Yes

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Shortened High-dose Palliative Radiotherapy for Lung Cancer
Stage IV Lung Cancer
Recruiting
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
Recruiting
Effect of Abdominal Massage Training Provided to Caregivers on Constipation Management
Constipation
Not yet recruitingPhase 1/2
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Intractable Pain, Palliative Care
RecruitingPhase 2
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Peritoneal Malignant Mesothelioma

All Palliative Care trials

Study at a glance

From the registry record, last updated by the sponsor on 27 Jul 2016. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Requests for Euthanasia and Assisted Suicide: a Prospective, Multicenter and Qualitative Study of Their Frequency and Characteristics, of Patients' Motivations and Their Evolution
ClinicalTrials.gov ID: NCT02845817
Acronym / sponsor ID: DESA / DESA
Conditions: Palliative Care, End of Life, Euthanasia, Assisted Suicide, Qualitative Research
Study type: Interventional
Recruitment status: Completed
Enrolment: 31 participants (actual)
Lead sponsor: Centre Hospitalier Universitaire de BesanconUniversity, hospital or other
Collaborators: Maison Médicale Jeanne Garnier
Study start: Sep 2014
Primary completion: Jun 2015 (actual)
Study completion: Jun 2015 (actual)
First posted: 27 Jul 2016 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Study design

Allocation: Not applicable
Intervention model: Single group
Masking: None (open label)
Number of arms: 1

Arm	Type	Receives
Qualitative research	Other	Other: Qualitative researchSemi-structured interviews

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult

Key inclusion criteria (7 listed)

Adult not under guardianship or curatorship,
Hospitalized in palliative care units of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier in Paris,
At the end of life due to advanced stage disease or a major change in the state of health of an elderly person,
They have made an explicit request for euthanasia or assisted suicide,
They are in capacity to meet researchers for interview,

Key exclusion criteria (7 listed)

Adult under guardianship or curatorship,
They are underage,
They are not hospitalized in Palliative Care Unit of Bourgogne-Franche-Comté region and in the Maison Médicale Jeanne Garnier,
The request was expressed by another person or not explicit,
They didn't consent to interviews,

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Interventions

Intervention	Type	Arms
Qualitative researchSemi-structured interviews	Other	Qualitative research

Primary outcome

70 semi-structured interviews
Time frame: 12 months
Qualitative data analysis - Theoretical concept saturation and thematic analyses. [analyze and understand the meaning of explicit requests to hasten death (euthanasia and assisted suicide)]

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 27 Jul 2016.

Related trials for Palliative Care

Active, not recruiting
Shortened High-dose Palliative Radiotherapy for Lung Cancer
Stage IV Lung Cancer
Recruiting
Adding Spatially Fractionated Radiation Therapy to Standard Palliative Radiation for Improving Disease-Related Symptoms in Patients With Unresectable Solid Tumors
Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
Recruiting
Effect of Abdominal Massage Training Provided to Caregivers on Constipation Management
Constipation
Not yet recruitingPhase 1/2
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Intractable Pain, Palliative Care
RecruitingPhase 2
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Peritoneal Malignant Mesothelioma

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Régis AUBRY, PR principal investigator

Centre Hospitalier Universitaire de Besancon

Danièle LEBOUL, MCU principal investigator

Maison Médicale Jeanne Garnier

Frédéric GUIRIMAND, DR principal investigator

Maison Médicale Jeanne Garnier

1 site in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

A study testing Qualitative research in people with Palliative Care and End of Life, run by Centre Hospitalier Universitaire de Besancon at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

70 semi-structured interviews (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02845817.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jul 2016.